Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Variable charge X-linked protein 2 (VCX2) is a small, highly charged nuclear protein encoded by a gene located in the VCX/Y gene family cluster on the human X chromosome (Xp22); the family has homologous genes on both X and Y chromosomes, typically expressed in male germ cells[1][2][4][8][9]. VCX2 contains tandem repeats of a 30-base pair sequence and exhibits a highly polymorphic copy number across individuals[1][4][8]. Its precise biological function remains uncharacterized, though gene ontology and protein studies speculate a role in spermatogenesis or in affecting sex ratio, based on expression patterns and family homology[3][9]. VCX2 is not recognized as a therapeutic target, lacks association with any approved drugs, and is not implicated as a biomarker or direct causative gene for major diseases, though gene family members have been linked to certain X-linked disorders[4][5][9].
Not established (due to the absence of therapeutic targeting and undefined function)[1][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Variable charge X-linked protein 2 (VCX2).